Physician profile
Smit Patel
NPI 1013442565
$103,067.84
in general payments reported to CMS, 2019-2025
12 companies · $701 in 2025
The $701 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $50K · 2023: $51K · 2024: $892 · 2025: $701.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $50K · Food and Beverage: $1,842 · Travel and Lodging: $1,113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $50,000.00 |
| Food and Beverage | $1,842.22 |
| Travel and Lodging | $1,112.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $101,378.60 | 2022-2025 | Apollotm, Pipeline |
| Microvention, INC. | $706.74 | 2024-2025 | Web Aneurysm Embolization System, Stent, Sofia 6f-131cm Str |
| Depuy Synthes Sales INC. | $398.28 | 2024-2025 | Trufill, Cerebase, Cerepak Uniform |
| Imperative Care, INC | $149.92 | 2023 | Zoom 88-T Large Distal Platform, Zoom Reperfusion Catheter |
| Astrazeneca Pharmaceuticals LP | $112.76 | 2022 | |
| Stryker Corporation | $103.76 | 2025 | Surpass Evolve |
| Balt USA, LLC | $93.10 | 2024 | Optima Coil System |
| Route 92 Medical, INC. | $31.31 | 2025 | |
| Cordis US Corp. | $30.78 | 2024-2025 | Mynx Control, Mynx Control Venous |
| Baxter Healthcare | $23.16 | 2025 | Floseal |
| Idorsia Pharmaceuticals US INC | $19.92 | 2023 | Quviviq |
| Terumo Medical Corporation | $19.51 | 2025 | R2p Misago |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Smit Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.